Patient Handling Equipment Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

With the rapid advancement in technology and the increasing number of hospitalization cases, the surging number of surgical cases has increased pressure on the hospitals and the medical staff for proper handling of patients. The manual handling of the patients is responsible for the increasing number of injuries among medical staff. In 2019, U.S. hospitals recorded 221,400 work-related injuries and illnesses, a rate of 5.5% work-related injuries and illnesses for every 100 full-time employees. Furthermore, the increasing concerns about patient safety significantly contribute to the market growth of the patient handling equipment market. Additionally, the growth of orthopedic rehabilitation centers induces the demand for patient-handling devices which are useful in the training.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21620

According to UnivDatos Market Insights (UMI)’ research report “Global Patient Handling Equipment Market Analysis, 2021”, the Patient Handling Equipment market is projected to grow at a CAGR of ~6% during 2021-27F. Deteriorating health coupled with the rising incidences of medical injuries is one of the major reasons of concern across the globe owing to the advancement in medical technology. These factors are driving the worldwide demand for cost-effective healthcare solutions augmenting the growth of the patient handling equipment market globally.

Based on the product type, the market is segmented into wheelchairs and scooters, medical beds, mechanical and nonmechanical equipment, ambulatory aids, and others. In 2020, the wheelchairs & scooter segment has a significant share of the patient handling equipment market due to the increasing number of patients in the hospitals and the surging geriatric population that requires proper treatment resulting in an increasing market size for the patient handling equipment. As per CDC, 17 % of Americans older than 65 years are hospitalized at least once during the year. 

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21620

Hospital Segment to Witness Robust growth

Based on End-users, the market is segmented into hospitals, home-care settings, and others. The hospital segment is expected to witness significant market growth during the forecast period. The segmental growth is due to the increasing number of medical injuries, the surging geriatric population, and an increasing number of orthopedic cases. Globally, a 33.4% increase in new fracture cases was reported in 2019 which accounted for 133.08 million cases in 2018 and reached 178 million cases in 2019.   

Europe to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, APAC dominated the global Patient Handling Equipment market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the well-established market players and frequent product launches. APAC is expected to skyrocket with a robust CAGR in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Patient Handling Equipment Market Analysis, 2021”. 

For more informative information, please visit us – https://univdatos.com/report/patient-handling-equipment-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the patient handling equipment market are Arjo, Hill-Rom Holdings Inc., Invacare Corporation, Stryker, Drive divibliss healthcare, Inc., ETAC AB, GF Health Products, Inc., Guldmann Inc., Handicare group AB, Joerns Healthcare LLC among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Patient Handling Equipment Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for patient handling equipment providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/patient-handling-equipment-market/

Market Segmentation:

1.      By Product Type (Wheelchairs And Scooters, Medical Beds, Mechanical and Nonmechanical Equipment, and Ambulatory Aids)

2.      By End-users (Hospitals, Home-Care Settings, and Others)

3.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

4.      By Company (are Arjo, Hill-Rom Holdings Inc., Invacare Corporation, Stryker, Drive divibliss healthcare, Inc., ETAC AB, GF Health Products, Inc., Guldmann Inc., Handicare group AB, Joerns Healthcare LLC., etc.)

Key questions answered in the study:

1.      What are the current and future trends of the patient handling equipment industry?

2.      How the industry has been evolving in terms of product type and end-users?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the Patient Handling Equipment industry?

5.      What is the customer orientation, purchase behavior, and expectations from the Patient Handling Equipment firms across various regions?

Table of Content –

1.    MARKET INTRODUCTION

2.    RESEARCH METHODOLOGY OR ASSUMPTION

3.    MARKET SYNOPSIS

4.    EXECUTIVE SUMMARY

5.    IMPACT OF COVID-19 ON THE PATIENT HANDLING EQUIPMENT MARKET

6.    PATIENT HANDLING EQUIPMENT MARKET REVENUE (USD BN), 2019-2027F

7.    MARKET INSIGHTS BY PRODUCT TYPE

8.    MARKET INSIGHTS BY END-USERS

9.    MARKET INSIGHTS BY REGION

10.   PATIENT HANDLING EQUIPMENT MARKET DYNAMICS

11.   PATIENT HANDLING EQUIPMENT MARKET OPPORTUNITIES

12.   PATIENT HANDLING EQUIPMENT MARKET TRENDS

13.   POLICY AND REGULATORY LANDSCAPE

14.   DEMAND AND SUPPLY-SIDE ANALYSIS

15.   COMPETITIVE SCENARIO

16.   COMPANY PROFILED

17.   DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        Hand Sanitizer Market Size Worth US$ 15.3 Billion by 2026 |CAGR: 9.15%|

·        Healthcare Cybersecurity Market to Reach US$ 41.8 Mn Billion by 2027 Globally |CAGR: 19.8%| 

·        Aesthetic Medicine Market to exceed US$ 19 Billion by 2027 Globally |CAGR: 10.5%|

Venous Stents Market to exceed US$ 2 Billion by 2027 Globally |CAGR: 9%|

Point-of-Care Ultrasound Device Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Diagnostic ultrasound, also called sonography or diagnostic medical sonography, is an imaging method that uses sound waves to produce images of structures within the body. The images can provide valuable information for diagnosing and directing treatment for a variety of diseases and conditions. Point-of-care ultrasound refers to the practice of trained medical professionals using ultrasound to diagnose problems wherever a patient is being treated. The increasing prevalence of cardiovascular and chronic diseases attributes to the surging demand for better diagnosis and treatment, thus supporting market growth. Additionally, the increased prevalence of musculoskeletal disorders due to improper nutrition is also a significant factor contributing to the global point of care ultrasound market.

Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21634  

According to ‘UnivDatos Market Insights (UMI)’ research report “Point-of-Care Ultrasound Device Market Analysis, 2020”, the Point-of-Care Ultrasound Device market is projected to grow at a CAGR of ~9% during 2021-27F.

Based on types the market has been bifurcated into diagnostics and therapeutics. During the forecast, the diagnostics segment is expected to witness significant growth. the rising prevalence of chronic diseases such as nephrolithiasis and cardiovascular diseases is attributed to the significant market share of the diagnostic segments in 2020. For instance, as per CDC, every year, about 805,000 people in the United States have a heart attack. Among them, the 605,000 are a first heart attack 200,000 happen to people who have already had a heart attack.

Based on end-users, the market is segmented into hospitals, clinics, and others. Among these, the hospital segment is predicted to have a major market share in the forecast period. Hospitals complement and amplify the effectiveness of many other parts of the health system, providing continuous availability of services for acute and complex conditions. Furthermore, the increasing number of surgeries in hospitals contributes to the development of the market.

 Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21634

North America to witness Significant Growth

For a better understanding of the market adoption of the point-of-care ultrasound device industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. During the forecast period, , North America is expected to have a higher CAGR due to higher investment in the healthcare infrastructure and more acceptability towards the adoption and integration of advanced technology in medical facilities. Furthermore, increased awareness about better health and increasing investments in health insurance contributes to the market in the along with the increasing prevalence of chronic diseases positively drives the medical diagnosis market.

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Point-of-Care Ultrasound Device Market Abbott Laboratories, Siemens Healthineers AG, Quidel Corporation, F. Hoffman-La Roche Ltd., Danaher Corporation, Becton Dickinson and Company, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech plc, Instrumentation Laboratory (a Werfen Company). The players are focused on launching new solutions and services, partnerships, and collaborations with major companies expanding their geographical reach to get a competitive edge in the industry.

 “Point-of-Care Ultrasound Device Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Point-of-Care Ultrasound Device providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/point-of-care-ultrasound-device-market/

Market Segmentation:

1.     By Portability (Trolley based devices and Handheld devices)

2.     By Application (Emergency Medicine, Cardiology, Obstetrics And Gynecology, Musculoskeletal, And Others)

3.     By Type (diagnostics and therapeutics)

4.     By End Users (Hospitals, Clinics, and Others)

5.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.     By Company (Abbott Laboratories, Siemens Healthineers AG, Quidel Corporation, F. Hoffman-La Roche Ltd., Danaher Corporation, Becton Dickinson and Company, Chembio Diagnostics, EKF Diagnostics, Trinity Biotech plc, Instrumentation Laboratory (a Werfen Company))

Key questions answered in the study:

1.     What are the current and future trends of the point-of-care ultrasound device industry?

2.     How the industry has been evolving in terms of portability, application, type, and end-users?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the point-of-care ultrasound device industry?

5.     What is the customer orientation, purchase behavior, and expectations from the point-of-care ultrasound device firms across various regions?  

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE POINT-OF-CARE ULTRASOUND DEVICE MARKET

6 POINT-OF-CARE ULTRASOUND DEVICE MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY PORTABILITY

8 MARKET INSIGHTS BY APPLICATION

9 MARKET INSIGHTS BY TYPE

10 MARKET INSIGHTS BY END-USER

11 MARKET INSIGHTS BY REGION

12 POINT-OF-CARE ULTRASOUND DEVICE MARKET DYNAMICS

13 POINT-OF-CARE ULTRASOUND DEVICE MARKET OPPORTUNITIES

14 POINT-OF-CARE ULTRASOUND DEVICE MARKET TRENDS

15 POLICY AND REGULATORY LANDSCAPE

16 DEMAND AND SUPPLY-SIDE ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Oncology Therapeutics Market to exceed US$ 247.5 Billion by 2027 Globally |CAGR: 8.2%|

·       Neuromodulation Devices Market to exceed US$ 11.7 Billion by 2027 Globally |CAGR: 8.4%| 

·       Digital Health Market to exceed US$ 746 Billion by 2027 Globally | CAGR: 26.3% |

·       Heart Pump Devices Market to exceed US$ 6 Billion by 2027 Globally | CAGR: 18.9% |

Data Resiliency Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Data Resiliency refers to data’s ability to recover in situations where it is compromised. It is related to digitally preserving organizational assets in the situation of a natural disaster or data center corruption. It is essentially an ability of an organization to avoid unexpected disruptions to data workflows. Additionally, data resiliency is also about responding to threats and recovering the lost or compromised data. Data threats and cyberattacks disarray the functioning of operational businesses. Furthermore, when data in a specific location becomes corrupted or inaccessible, availability is improved when multiple copies of data are stored in multiple locations. Users and applications are still able to access data as they are directed to a secondary location where the same data is not compromised. Ultimately, to ensure data resiliency, organizations must protect data in a number of different locations.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21649

According to UnivDatos Market Insights (UMI)’ research report “Data Resiliency Market” is predicted to grow at a CAGR of around 17% during the forecast period. This can be mainly attributed to the increasing cyber-attacks in various industries coupled with high growth in data generated throughout the years.

Based on deployment, the market is categorized into on-premises and cloud. Among these two, on-premises held a prominent share of the data resiliency market and is expected to be the prominent market shareholder during the forecast period. The growth in this segment can be attributed to the high speed and low latency abilities of on-premises deployment. On-premises deployment is preferred by organizations, which are looking for high performance for multiple types of workloads. Industries such as government, defense, and banking, prefer the on-premises deployment, as they cannot afford to lose sensitive data, financial records, customer data, and money transaction information in any situation.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21649

Based on Industry, the market is segmented into banking and financial services, information and communication technology, government, media and entertainment, healthcare, and others. In 2020, banking and financial services accounted for a substantial share in the global data resiliency market due to the need for high data security and appropriate backup in the banking sector. The banking and financial industry generates and processes massive volumes of data on daily basis. Further on, data resiliency helps the banking and financial services industry to backup and recover data to maintain business continuity.

Asia-Pacific is expected to witness robust growth

For a better understanding of the market adoption of the data resiliency industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. APAC is expected to showcase robust growth during the forecast period mainly due to the growing awareness across various industries such as banking and financial services, information and communication technology, government, and healthcare to protect and backup their crucial enterprise data. Cyberattacks and ransomware attacks are also driving the growth of the data resiliency market in the APAC region.

For more informative information, please visit us – https://univdatos.com/report/data-resiliency-market/

According to ‘UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the data resiliency market include Acronis International GmbH, Microsoft Corporation, Asigra Inc., International Business Machines Corporation, NetApp Inc., VMware Inc., Veritas Technologies LLC., Carbonite Inc., Hewlett Packard Enterprise, and Veeam Software AG.

“Data Resiliency Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.     

For more informative information, please visit us – https://univdatos.com/report/data-resiliency-market/

Market Segmentation:

1.      By Type (Solutions and Services)

2.      By Deployment (On-premises and Cloud)

3.      By Organization size (Large Enterprises and SMEs)

4.      By Industry (Banking and Financial Services, Information and Communication Technology, Government, Media and Entertainment, Healthcare, and Others)

5.      By Region (North America, Europe, Asia-Pacific, Rest of World)

6.      By Company (Acronis International GmbH, Microsoft Corporation, Asigra Inc., International Business Machines Corporation, NetApp Inc., VMware Inc., Veritas Technologies LLC., Carbonite Inc., Hewlett Packard Enterprise, and Veeam Software AG)

Key questions answered in the study:

1.      What are the current and future trends of the data resiliency industry?

2.      How the industry has been evolving in terms of type, deployment, organization size, and industry category?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the data resiliency industry?

5.      What are the customer orientation, purchase behavior, and expectations from the data resiliency product suppliers across various countries?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE DATA RESILIENCY MARKET

6 DATA RESILIENCY MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

8 MARKET INSIGHTS BY DEPLOYMENT

9 MARKET INSIGHTS BY ORGANIZATION SIZE

10 MARKET INSIGHTS BY INDUSTRY

11 MARKET INSIGHTS BY REGION

12 DATA RESILIENCY MARKET DYNAMICS

13 DATA RESILIENCY MARKET OPPORTUNITIES

14 DATA RESILIENCY MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        Asia-Pacific Digital Transformation Market to exceed US$ 1,334 Billion by 2027 Globally |CAGR: 13.5%

·        CPG Digital Marketing Market to Reach US$ 60.6 Billion by 2027, Globally |CAGR: 7.8%|

·        Digital Advertisement Market to Reach US$ 626 Billion by 2026, Globally |CAGR: 7.7%|

·        MENA 3D Printing Market is expected to exceed US$ 1 Billion by 2025 |CAGR: 12.7%|

Diabetes Supplement Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The presence of well-established healthcare infrastructure and higher adoption of nutraceuticals in the country. Also, the country is witnessing the growing prevalence of prediabetes coupled with the rising geriatric population. For instance, according to the CDC, 96 million people aged 18 years or older have prediabetes (38.0% of the adult US population), and 26.4 million people aged 65 years or older (48.8%) have prediabetes. Furthermore, some other factors boosting the market growth in the country include the increasing cases of obesity owing to the sedentary lifestyles.

The recent COVID-19 pandemic has disrupted the healthcare industry with the emergence of SARS-COV-2. As of March 16, 2021, there have been almost 121 million cases of COVID-19 worldwide. The disease has impacted more than 210 countries and territories, with the United States confirming around one-fifth of all global cases. With this huge surge in the covid cases, the demand for diabetes supplements has also witnessed an uptick as COVID-19 patients as more at a higher risk of diabetes.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21661

According to UnivDatos Market Insights (UMI)’ research report “Global Diabetes Supplement Market Analysis, 2020”, the Diabetes Supplement Market is projected to grow at a CAGR of around 4% during 2021-27F. A large number of ongoing research activities in this field, rising government and public-private investments, and various advantages associated with the diabetes supplements such as controlling blood sugar, preventing diabetes-related complications, and reducing resistance to insulin.

Based on distribution channels, the market is fragmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2020, the retail pharmacies segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the availability of retail pharmacies in every small area or city. However, the online segment is also significantly growing due to internet users, ease of access to several brands, 24/7 availability of products, the convenience of shopping, and a wide range of products offered.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21661

Geriatric Segment to Witness Robust growth

Based on end-users, the market is fragmented into adults, geriatric, and children. In 2020, the geriatric segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the surge of the geriatric population and the growth of the diabetes cases as they are prone to these diseases. For instance, as per NCBI, About 40% (39.5%) of the adult diabetic population is age ≥65 years. Approximately 20% (21.4%) of adults aged≥65 years have a known diagnosis of diabetes.

 

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global diabetes supplement market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of well-established market players and frequent product launches in the region. North America is expected to skyrocket with a considerable CAGR in the forecast period, as stated in UnivDatos Market Insights (UMI)’ research report “Global Diabetes Supplement Market Analysis, 2020”. 

For more informative information, please visit us – https://univdatos.com/report/diabetes-supplement-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Diabetes supplement Market include Novo Nordisk, Nestlà Health Science, Danone Nutricia, NaturoGain, Nature's Bounty, Glucose Health, Inc, Unilever, Bionova Lifesciences, Caelus Health, Abbott among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Diabetes Supplement Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for diabetes supplement providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/diabetes-supplement-market/

Market Segmentation:

1.      By Ingredients (Vitamins, Minerals, Proteins, Antioxidants & Fatty Acids, Dietary Fibers, and Others)

2.      By Disease Type (Type 1 and Type 2)

3.      By Forms (Tablets, Solution, Powder, and Others)

4.      By Region (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies)

5.      By End-Users (Adults, Geriatric, and Children)

6.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

7.      By Company (Novo Nordisk, Nestle Health Science, Danone Nutricia, NaturoGain, Nature's Bounty, Glucose Health, Inc, Unilever, Bionova Lifesciences, Caelus Health, Abbott Laboratories)

Key questions answered in the study:

1.      What are the current and future trends of the diabetes supplement industry?

2.      How the industry has been evolving in terms of ingredients, disease type,  forms, distribution channel, and end-users?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the diabetes supplement industry?

5.      What is the customer orientation, purchase behavior, and expectations from diabetes supplement firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL DIABETES SUPPLEMENT MARKET COVID-19 IMPACT

6 GLOBAL DIABETES SUPPLEMENT MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY INGREDIENTS

8 MARKET INSIGHTS BY DISEASE TYPE

9 MARKET INSIGHTS BY FORMS

10 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

11 MARKET INSIGHTS BY END-USERS

12 MARKET INSIGHTS BY REGION

13 DIABETES SUPPLEMENT MARKET DYNAMICS

14 DIABETES SUPPLEMENT MARKET OPPORTUNITIES

15 DIABETES SUPPLEMENT MARKET TRENDS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

20 COMPANY PROFILED

21 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% |

·        Gene Therapy Market to Reach US$ 20.9 Billion by 2027, Globally |CAGR: 29.7%|

·        Healthcare Cloud Computing Market to Reach US$ 80.5 Billion by 2027 Globally |CAGR: 14.5%| 

·        Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%| 

Digital Pathology Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Global digital pathology market is expected to register a CAGR of around 10% over the period of 2021-2027. The rising prevalence of chronic diseases is expected to increase the clinical urgency of adopting digital pathology to improve the patient's existing diagnostic imaging modality and reduce the high costs associated with the traditional diagnosis. In addition, an increasing population of elderly people who are prone to chronic diseases is expected to drive demand for technologically advanced diagnostic techniques. According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Owing to the glaring statistics, rising prevalence of cardiovascular diseases (CVDs), it becomes imperative to opt for advanced diagnostic and imaging alternatives.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21674  

According to UnivDatos Market Insights (UMI)’ research report “global digital pathology market”, the market is expected to witness robust growth during the forecast period 2021-2027F. Advances in digital imaging, computerization, robot light microscopy, and multiple fiber optic communications are also contributing to growth. In addition, the adoption of AI in healthcare is increasing, with an increasing focus on improving the quality of patient care by using AI in various aspects of healthcare services, such as pathological diagnosis is used. AI-based tools, such as clinical decision support systems, can help streamline hospital workflows, improve healthcare, and thereby improving the patient experience. 

Based on application, the market is classified into teleconsultation, training, disease diagnosis, and drug discovery. Amongst application types, the drug discovery category accounted for a significant share of the market. The drug discovery category accounted for a significant share of the market due to an increase in the prevalence of rare diseases and growing R&D activities in the drug development process.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21674

 Based on end-user, the market is classified into pharmaceutical & biotechnology companies, academic and research, and hospitals. Amongst end-users, the pharmaceutical & biotechnology company’s category accounted for a significant share in the market due to the development of novel & innovative pathology systems, and advancement in R&D activities contributing to the growth of the market. 

North America to witness extensive growth

For a better understanding of the market adoption of digital pathology market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the digital pathology industry and generated major revenue in 2020 owing to the presence of well-established market players and the rising geriatric population in the region.

For more informative information, please visit us – https://univdatos.com/report/digital-pathology-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global digital pathology market are 3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche (Roche), Visiopharm A/S. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions. 

“Global Digital Pathology Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.      

For more informative information, please visit us –  https://univdatos.com/report/digital-pathology-market/

Market Segmentations:

1.     By Product Type (Scanner, Software, and Storage System)

2.     By Type (Human and Veterinary)

3.     By Application (Teleconsultation, Training, Disease Diagnosis, and Drug Discovery)

4.     By End-Users (Pharmaceutical & Biotechnology Companies, Academic and Research, and Hospitals)

5.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.     By Company (3dhistech Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, Perkinelmer Inc., F- Hoffmann La-Roche, Visiopharm A/S.)  

Key questions answered in the study:

1.     What are the current and future trends of the global digital pathology industry?

2.     How the industry has been evolving in terms of technology and application?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the global digital pathology industry?

5.     What is the customer orientation, purchase behavior, and expectations from the global digital pathology suppliers across various region and countries? 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL DIGITAL PATHOLOGY MARKET COVID-19 IMPACT

6 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

8 MARKET INSIGHTS BY TYPE

9 MARKET INSIGHTS BY APPLICATION

10 MARKET INSIGHTS BY END-USERS

11 MARKET INSIGHTS BY REGION

12 DIGITAL PATHOLOGY MARKET DYNAMICS

13 DIGITAL PATHOLOGY MARKET OPPORTUNITIES

14 DIGITAL PATHOLOGY MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

19 COMPANY PROFILED

20 DISCLAIMER 

Browse Other Related Research Reports from UnivDatos Market Insights

·       Ophthalmic Devices Market to Reach US$ 46.3 Billion by 2026, Globally |CAGR: 5.2%|

·       Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% |

·       Artificial Intelligence (AI) in Healthcare Market to Reach US$ 26.5 Billion by 2025, Globally |CAGR: 41%|

·       In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|